Chronic inflammation role in the obesity-diabetes association: A case-cohort study

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Luft, Vivian C ^a   Schmidt, Maria I ^a,b   Pankow, James S ^c   Couper, David ^b   Ballantyne, Christie M ^d   Young, J Hunter ^e   Duncan, Bruce B ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipokines; Diabetes; Epidemiologic studies; Humans; Inflammation; Obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FIBRINOGEN; INSULIN; INTERLEUKIN 6; LEPTIN; OROSOMUCOID;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UPREGULATION; WAIST CIRCUMFERENCE;

EID: 84879423746     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-31     Document Type: Article

References (38)

1. World Health Organization, Fact sheet N°312 [ http://www.who.int/ mediacentre/factsheets/fs312/en/print.html ] 23430773
2. Prevalence of overweight and obesity in the United States, 1999-2004. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM, JAMA 2006 295 1549 1555 10.1001/jama.295.13.1549 16595758
3. How obesity causes diabetes: not a tall tale. Lazar MA, Science 2005 307 373 375 10.1126/science.1104342 15662001 (Pubitemid 40139971)
4. Getting the message across: mechanisms of physiological cross talk by adipose tissue. Lee DE, Kehlenbrink S, Lee H, Hawkins M, Yudkin JS, Am J Physiol Endocrinol Metab 2009 296 1210 E1229 10.1152/ajpendo.00015.2009 19258492
5. Subclinical inflammation and obesity, diabetes and related disorders. Schmidt MI, Saad MJA, Duncan BB, Drug Discov Today Dis Mech 2005 2 307 312 10.1016/j.ddmec.2005.08.003
6. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Hotamisligil GS, Spiegelman BM, Diabetes 1994 43 1271 1278 10.2337/diabetes.43.11.1271 7926300
7. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G, Lancet 1999 353 1649 1652 10.1016/S0140-6736(99)01046-6 10335783 (Pubitemid 29224520)
8. The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Duncan BB, Schmidt MI, Diabetes Technol Ther 2006 8 7 17 10.1089/dia.2006.8.7 16472046
9. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G, Diabetes 2003 52 1799 1805 10.2337/diabetes.52.7.1799 12829649 (Pubitemid 36792473)
10. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G, Diabetes 2004 53 2473 2478 10.2337/diabetes.53.9.2473 15331562 (Pubitemid 39145606)
11. Leptin and incident type 2 diabetes: risk or protection? Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G, Diabetologia 2006 49 2086 2096 10.1007/s00125-006-0351-z 16850292 (Pubitemid 44168476)
12. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS, Diabetologia 2007 50 36 42 17136392 (Pubitemid 46035850)
13. Collett D, Modelling survival data in medical research London: Chapman & Hall 1994
14. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Adult Treatment Panel III, Circulation 2002 106 3143 12485966
15. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y, Nat Med 2002 8 731 737 10.1038/nm724 12068289 (Pubitemid 34778727)
16. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. Li S, Shin HJ, Ding EL, van Dam RM, JAMA 2009 302 179 188 10.1001/jama.2009.976 19584347
17. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Aggarwal BB, Annu Rev Nutr 2010 30 173 199 10.1146/annurev.nutr.012809.104755 20420526
18. Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. Wong TY, Klein R, Sharrett AR, Schmidt MI, Pankow JS, Couper DJ, Klein BEK, Hubbard LD, Duncan BB, for the ARIC Investigators, JAMA 2002 287 2528 2533 10.1001/jama.287.19.2528 12020333 (Pubitemid 34517198)
19. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Sartipy P, Loskutoff DJ, PNAS 2003 100 7265 7270 10.1073/pnas.1133870100 12756299 (Pubitemid 36706427)
20. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults-the ARIC study. Atherosclerosis Risk in Communities. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G, Obes Res 2000 8 279 286 10.1038/oby.2000.33 10933303
21. Inflammation-sensitive plasma proteins are associated with future weight gain. Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F, Diabetes 2003 52 2097 2101 10.2337/diabetes.52.8.2097 12882928 (Pubitemid 36919804)
22. Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease. Egger G, Dixon J, Obes Rev 2010 11 137 149 10.1111/j.1467-789X.2009.00644.x 19656309
23. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D, Diabetes 2004 53 701 710 10.2337/diabetes.53.3.701 14988255 (Pubitemid 38270640)
24. Endoplasmic reticulum stress: another link between obesity and insulin resistance/inflammation? Boden G, Diabetes 2009 58 518 519 19246600
25. From endoplasmic-reticulum stress to the inflammatory response. Zhang K, Kaufman RJ, Nature 2008 454 455 462 10.1038/nature07203 18650916
26. Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic beta-cells. Lai E, Bikopoulos G, Wheeler MB, Rozakis-Adcock M, Volchuk A, Am J Physiol Endocrinol Metab 2008 294 540 E550 10.1152/ajpendo.00478.2007 18198352 (Pubitemid 351355224)
27. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Boden G, Duan X, Homko C, Molina EJ, Song W, Perez O, Cheung P, Merali S, Diabetes 2008 57 2438 2444 10.2337/db08-0604 18567819
28. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. Gregor MF, Hotamisligil GS, J Lipid Res 2007 48 1905 1914 10.1194/jlr.R700007-JLR200 17699733 (Pubitemid 47360610)
29. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. Lin Y, Berg AH, Iyengar P, Lam TKT, Giacca A, Combs TP, Rajala MW, Du X, Rollman B, Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, Scherer PE, J Biol Chem 2005 280 4617 4626 15536073 (Pubitemid 40288630)
30. Mitochondrial dysfunction and type 2 diabetes. Lowell BB, Shulman GI, Science 2005 307 384 387 10.1126/science.1104343 15662004 (Pubitemid 40139974)
31. Leptin and the regulation of body weight in mammals. Friedman JM, Halaas JL, Nature 1999 95 107 136
32. Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. Guzik TJ, Marvar PJ, Czesnikiewicz G, Korbut R, J Physiol Pharmacol 2007 58 591 610 18204173
33. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Rebrin K, Steil GM, Getty L, Bergman RN, Diabetes 1995 44 1038 1045 10.2337/diabetes.44.9.1038 7657026
34. Fasting plasma free fatty acids and risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Pankow JS, Duncan BB, Schmidt MI, Ballantyne CM, Couper DJ, Hoogeveen RC, Golden SH, Diabetes Care 2004 27 77 82 10.2337/diacare.27.1.77 14693970 (Pubitemid 38196713)
35. A further critique of the analytic strategy of adjusting for covariates to identify biologic mediation. Kaufman JS, Maclehose RF, Kaufman S, Epidemiol Perspect Innov 2004 1 4 10.1186/1742-5573-1-4 15507130 (Pubitemid 40404935)
36. Early-life and adult socioeconomic status and inflammatory risk markers in adulthood. Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G, Eur J Epidemiol 2007 22 55 66 10.1007/s10654-006-9082-1 17225957 (Pubitemid 46208247)
37. Cumulative socioeconomic status across the life course and subclinical atherosclerosis. Carson AP, Rose KM, Catellier DJ, Kaufman JS, Wyatt SB, ez-Roux AV, Heiss G, Ann Epidemiol 2007 17 296 303 10.1016/j.annepidem.2006.07.009 17027292 (Pubitemid 46454378)
38. Inflammation, insulin resistance, and diabetes - Mendelian randomization using CRP haplotypes points upstream. Brunner EJ, Kivimaki M, Witte DR, Lawlor DA, Vey Smith G, Cooper JA, Miller M, Lowe GD, Rumley A, Casas JP, Shah T, Humphries SE, Hingorani AD, Marmot MG, Timpson NJ, Kumari M, PLoS Med 2008 5 155 10.1371/journal.pmed.0050155 18700811 Diseases